3-121770148-C-G
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001023570.4(IQCB1):c.*197G>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.619 in 563,820 control chromosomes in the GnomAD database, including 110,383 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.64 ( 31987 hom., cov: 32)
Exomes 𝑓: 0.61 ( 78396 hom. )
Consequence
IQCB1
NM_001023570.4 3_prime_UTR
NM_001023570.4 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.162
Genes affected
IQCB1 (HGNC:28949): (IQ motif containing B1) This gene encodes a nephrocystin protein that interacts with calmodulin and the retinitis pigmentosa GTPase regulator protein. The encoded protein has a central coiled-coil region and two calmodulin-binding IQ domains. It is localized to the primary cilia of renal epithelial cells and connecting cilia of photoreceptor cells. The protein is thought to play a role in ciliary function. Defects in this gene result in Senior-Loken syndrome type 5. Alternative splicing results in multiple transcript variants. A pseudogene of this gene is found on chromosome 6. [provided by RefSeq, Jan 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 3-121770148-C-G is Benign according to our data. Variant chr3-121770148-C-G is described in ClinVar as [Benign]. Clinvar id is 342768.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.708 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
IQCB1 | NM_001023570.4 | c.*197G>C | 3_prime_UTR_variant | 15/15 | ENST00000310864.11 | NP_001018864.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IQCB1 | ENST00000310864 | c.*197G>C | 3_prime_UTR_variant | 15/15 | 1 | NM_001023570.4 | ENSP00000311505.6 | |||
IQCB1 | ENST00000349820 | c.*197G>C | 3_prime_UTR_variant | 12/12 | 1 | ENSP00000323756.7 | ||||
IQCB1 | ENST00000393650.7 | n.*972G>C | non_coding_transcript_exon_variant | 14/14 | 5 | ENSP00000377261.3 | ||||
IQCB1 | ENST00000393650.7 | n.*972G>C | 3_prime_UTR_variant | 14/14 | 5 | ENSP00000377261.3 |
Frequencies
GnomAD3 genomes AF: 0.644 AC: 97819AN: 151922Hom.: 31955 Cov.: 32
GnomAD3 genomes
AF:
AC:
97819
AN:
151922
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.610 AC: 251056AN: 411780Hom.: 78396 Cov.: 3 AF XY: 0.611 AC XY: 132507AN XY: 217012
GnomAD4 exome
AF:
AC:
251056
AN:
411780
Hom.:
Cov.:
3
AF XY:
AC XY:
132507
AN XY:
217012
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.644 AC: 97902AN: 152040Hom.: 31987 Cov.: 32 AF XY: 0.645 AC XY: 47951AN XY: 74330
GnomAD4 genome
AF:
AC:
97902
AN:
152040
Hom.:
Cov.:
32
AF XY:
AC XY:
47951
AN XY:
74330
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | Nov 12, 2018 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Senior-Loken syndrome 5 Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 12, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at